NEFL and early-onset autosomal dominant Alzheimer disease: Our findings are broadly consistent with previous studies in predominantly non-Hispanic White populations, such as those from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) and the Mayo Clinic Study of Aging, which have demonstrated that elevated levels of plasma pTau-181 and NfL are associated with worse cognitive performance and greater risk of ADRDs12,46.